Raymond Furey

Raymond Furey

Compliance Officer at RIGEL PHARMACEUTICALS, INC.

Net worth: 2 M $ as of 29/06/2026

58 year
Health Technology
Consumer Services
Commercial Services

Profile

Raymond J.
Furey
is Secretary, Chief Compliance Officer & Executive Vice President at Rigel Pharmaceuticals, Inc. since 2022.
Member of the New York State Association of Realtors.
Member of the U.S.
Supreme Court Bar Association.
Formerly Compliance Officer at OSI Pharmaceuticals, Inc. Chief Compliance Officer & Senior Vice President at Questcor Pharmaceuticals, Inc. from 2013 to 2014.
Chief Compliance Officer & Senior Vice President at Keenova Therapeutics Plc.
Chief Compliance Officer & Senior Vice President at Portola Pharmaceuticals LLC from 2017 to 2020.
SVP-Chief Compliance Officer & General Counsel at Turning Point Therapeutics, Inc. from 2021 to 2022.
Chief Operating Officer at ARA Pharmaceuticals, Inc. from 2020 to 2021.
Education includes an MBA from San Francisco State University, undergraduate studies at Trinity College Dublin, and graduate studies at Fordham University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/06/2026 50,936 ( 0.28% ) 2 M $ 29/06/2026

Raymond Furey active positions

CompaniesPositionStart
RIGEL PHARMACEUTICALS, INC. Compliance Officer 30/11/2022
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Raymond Furey

CompaniesPositionEnd
TURG POIN Compliance Officer 31/07/2022
ARA Pharmaceuticals, Inc.
Chief Operating Officer 28/02/2021
PORTOLA PHARMACEUTICALS, INC. Compliance Officer 31/08/2020
QUESTCOR PHARMACEUTICALS INC Compliance Officer 21/08/2014
MALLINCKRODT PLC Compliance Officer -
See the detail of Raymond Furey's experience

Training of Raymond Furey

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

ARA Pharmaceuticals, Inc.